SCHEMBL6325213

SCHEMBL6325213

CCCC(C)c1c(O)cccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
HDAC4 P56524 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
IAPP P10997 5/20 0.37
GABRA1 P14867 3/20 0.37
GABRB2 P47870 3/20 0.37
CA1 P00915 5/20 0.35
CA2 P00918 5/20 0.35
CA9 Q16790 3/20 0.35
CA12 O43570 2/20 0.35
CA7 P43166 2/20 0.35
CA14 Q9ULX7 2/20 0.35
HPGD P15428 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676779 0.88 TSHR (0.50) TSHRHDAC4HDAC2HDAC8ALDH1A1
SCHEMBL9281627 0.84 ALDH1A1 (0.46) TSHRALDH1A1MAPTHTTMEN1
SCHEMBL31545285 0.84 ALDH1A1 (0.46) TSHRALDH1A1MAPTHTTMEN1
SCHEMBL31545167 0.84 ALDH1A1 (0.46) TSHRALDH1A1MAPTHTTMEN1
SCHEMBL9923796 0.83 TRPA1 (0.46) TSHRHDAC4HDAC2HDAC8ALDH1A1
SCHEMBL3576125 0.82 TSHR (0.61) TSHRHDAC4HDAC2HDAC8ALDH1A1
SCHEMBL4783448 0.81 ABL1 (0.36) TSHRHDAC4HDAC2HDAC8ALDH1A1
SCHEMBL28343869 0.80 TSHR (0.59) TSHRHDAC4HDAC2HDAC8ALDH1A1
SCHEMBL6334263 0.80 ESR1 (0.41) TSHRHDAC4HDAC2HDAC8ALDH1A1
SCHEMBL25061470 0.78 MEN1 (0.38) TSHRMEN1KMT2ACYP3A4TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026098831-A1 USE OF A PERSONAL CARE COMPOSITION FOR IMPROVING THE BARRIER FUNCTION OF SKIN UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO claimed
WO-2026041386-A1 ANHYDROUS COMPOSITION COMPRISING MONOESTERS AND MAINLY PETROLATUM UNILEVER IP HOLDINGS B.V. (NL) 2026-02-26 WO claimed
EP-3675806-B1 PERSONAL CARE COMPOSITION UNILEVER GLOBAL IP LTD (GB) 2026-01-21 EP claimed
EP-4637692-A1 COLOR STABILIZATION OF FORMULAE WITH AN INDOLE Unilever IP Holdings B.V. (NL) 2025-10-29 EP claimed
WO-2025132281-A1 COSMETIC COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2025-06-26 WO claimed
WO-2024132395-A1 COLOR STABILIZATION OF FORMULAE WITH AN INDOLE UNILEVER IP HOLDINGS B.V. (NL) 2024-06-27 WO claimed
CN-111182881-B Personal care compositions 联合利华知识产权控股有限公司 2023-08-11 CN claimed
US-11478411-B2 Use of chelating agents for improving color stability of resorcinol CONOPCO, INC. (US) 2022-10-25 US claimed
US-11324679-B2 Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors CONOPCO, INC. (US) 2022-05-10 US claimed
WO-2021249760-A1 A COSMETIC COMPOSITION COMPRISING 6-METHYL-PICOLINAMIDE UNILEVER IP HOLDINGS B.V. (NL) 2021-12-16 WO claimed
US-6869598-B2 Stabilization of sunscreens in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) 2005-03-22 US claimed
US-6863897-B2 Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) 2005-03-08 US claimed
US-6858217-B2 Stabilization of terpenoids in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) 2005-02-22 US claimed
EP-1490017-A1 STABILIZATION OF SUNSCREENS IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2004-12-29 EP claimed
US-20030185773-A1 Stabilization of sunscreens in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-10-02 US claimed
US-20030185867-A1 Stabilization of terpenoids in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-10-02 US claimed
WO-2003080011-A1 STABILIZATION OF TERPENOIDS IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2003-10-02 WO claimed
WO-2003080009-A1 STABILIZATION OF SUNSCREENS IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2003-10-02 WO claimed
WO-2003080002-A1 STABILIZATION OF RESORCINOL DERIVATIVES IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2003-10-02 WO claimed
US-20030180234-A1 Stabilization of resorcinol derivatives in cosmetic compositions UNILEVER HOME & PERSONAL CARE USA, 2003-09-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030185773-A1 Stabilization of sunscreens in cosmetic compositions RCOR1, CBR1, NQO1 TSHR 2772/4885HDAC4 451/4885HDAC2 264/4885
US-11324679-B2 Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors RARA, RARB, RBP4 TSHR 3173/4885HDAC4 1941/4885HDAC2 4249/4885
US-20030180234-A1 Stabilization of resorcinol derivatives in cosmetic compositions RCOR1, RCOR3, MCOLN2 TSHR 1528/4885HDAC4 339/4885HDAC2 263/4885
US-20030185867-A1 Stabilization of terpenoids in cosmetic compositions SQLE, CYP51A1, RBP4 TSHR 3376/4885HDAC4 224/4885HDAC2 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.